SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Beckman Daniella

(Last)

(First)

(Middle)

C/O TANGO THERAPEUTICS, INC.

100 BINNEY STREET, SUITE 700

(Street)

CAMBRIDGE

02142

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/10/2021

3. Issuer Name and Ticker or Trading Symbol
Tango Therapeutics, Inc. [ TNGX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	63,867	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	10/18/2029	Common Stock	165,443	1.531	D
Stock Option (Right to Buy)	⁽²⁾	01/30/2030	Common Stock	55,204	1.648	D
Stock Option (Right to Buy)	⁽³⁾	10/01/2030	Common Stock	68,114	3.209	D
Stock Option (Right to Buy)	⁽⁴⁾	01/28/2031	Common Stock	88,157	3.503	D

Explanation of Responses:

1. This option shall vest and become exercisable in equally monthly installments over a period of 48 months from September 10, 2019.

2. This option shall vest and become exercisable in monthly installments over a period of 48 months from November 1, 2019.

3. This option shall vest and become exercisable in monthly installments over a period of 48 months from July 1, 2020.

4. This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2021, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24: Power of Attorney

	By: /s/ William Collins, as attorney-in-fact	08/12/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 3: Beckman Daniella claimed ownership of 63,867 units of Common Stock